Founded in 2001, HBM Partners has a team of experienced professionals who source, analyze, and engage in investments in the biopharma, medical devices, and diagnostics industries. They have a track record of over 100 investments resulting in significant value creation through trade sales and IPOs. HBM Partners focuses on venture, growth, and buy-out financings of private companies, as well as investments in public companies. They typically invest between $5 million to $50 million and have a portfolio of 37 companies.